If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Form 8

7 Mar 2024 15:00

RNS Number : 8966F
Jaywing PLC
07 March 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Jaywing plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Jaywing plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

 The latest practicable date prior to the disclosure

6 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of £0.05

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

3(a) Interests held by the directors of Jaywing Plc and their close relatives and related trusts (excluding options and awards which are set out in 3(b) below):

 

Director

Position

Number of ordinary shares

Percentage of issued share capital1

Andrew Fryatt

Chief Executive

120,993

0.12%

Ian Robinson

Non-Executive Director

470,267

0.50%

Philip Hanson

Non-Executive Director

109,462

0.11%

1 Based on total voting rights in the Company is 93,332,595.

 

3(b) Options and awards held by certain directors of Jaywing Plc in ordinary shares issued under the LTIP / CSOP:

 

 

 

 

 

Date of Grant

 

 

 

 

Name of option holder

Number of ordinary shares under outstanding options

 

 

 

 

Vesting Date

 

 

Expiry Date

 

 

 

Exercise Price (p)

13 April 2023,

Andrew Fryatt (CSOP)

1,200,000

13 April 2026

13 April 2033

5p

13 April 2023,

Andrew Fryatt (LTIP)

576,000

13 April 2025

13 April 2033

5p

13 April 2023,

Andrew Fryatt (LTIP)

576,000

13 April 2027

13 April 2033

5p

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

6 March 2024

 

Contact name:

Christoper Hughes CFO

Telephone number:

44 (0)333 370 6500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGZGGFRVDGDZM
Date   Source Headline
6th Jan 20121:43 pmRNSHolding(s) in Company
6th Jan 20129:53 amRNSChange of Adviser
16th Dec 20112:07 pmRNSExercise of Options/Total Voting Rights
6th Dec 201112:30 pmRNSHolding(s) in Company
22nd Nov 20117:00 amRNSInterim Results 2011/2012
27th Sep 201112:25 pmRNSChange of Name
5th Sep 201112:19 pmRNSResult of AGM
2nd Sep 201112:00 pmRNSHolding(s) in Company
1st Sep 201112:24 pmRNSHolding(s) in Company
13th Jul 20117:00 amRNSFinal Results
23rd Jun 20117:00 amRNSNotice of Results
20th May 201110:30 amRNSHolding(s) in Company
18th May 201111:42 amRNSHolding(s) in Company
18th May 20118:05 amRNSHolding(s) in Company
10th May 20118:55 amRNSTotal Voting Rights
6th May 201110:30 amRNSHolding(s) in Company
4th Apr 20117:50 amRNSDirectorate Change
8th Feb 20118:33 amRNSTotal Voting Rights
13th Jan 201111:18 amRNSTotal Voting Rights
6th Dec 20104:23 pmRNSTransaction in Own Shares
2nd Dec 20107:00 amRNSTransaction in Own Shares
23rd Nov 20107:00 amRNSHalf Yearly Report
28th Oct 20103:14 pmRNSNotice of Results and Trading Update
30th Sep 20109:26 amRNSTotal Voting Rights
27th Sep 20102:10 pmRNSAnnual Financial Report
6th Sep 20105:14 pmRNSIssue of Equity
3rd Sep 201011:27 amRNSResult of AGM
3rd Sep 20107:00 amRNSAGM Statement
31st Aug 20101:04 pmRNSHolding(s) in Company
13th Aug 20103:30 pmRNSIssue of Equity
27th Jul 201012:52 pmRNSChange of Adviser
22nd Jul 201010:25 amRNSHolding(s) in Company
22nd Jul 201010:23 amRNSIssue of Equity
15th Jul 20107:00 amRNSDirector/PDMR Shareholding
9th Jul 201011:25 amRNSIssue of Equity
2nd Jul 20107:00 amRNSFinal Results
13th May 201012:03 pmRNSAdditional Listing
6th May 20102:47 pmRNSAdditional Listing
22nd Apr 20107:00 amRNSDirector/PDMR Shareholding
21st Apr 20105:13 pmRNSDirector/PDMR Shareholding
14th Apr 201012:37 pmRNSTwo Pillar Business Strategy
15th Mar 20104:18 pmRNSIssue of Equity
24th Feb 20103:16 pmRNSIssue of Equity
5th Feb 20103:05 pmRNSDirector/PDMR Shareholding
4th Feb 20101:00 pmRNSIssue of Equity
18th Jan 20108:00 amRNSDMG named UK's largest digital marketing business
11th Jan 20102:00 pmRNSDirector/PDMR Shareholding
5th Jan 20104:54 pmRNSHolding(s) in Company
23rd Dec 200910:30 amRNSIssue of equity and Director Dealing
14th Dec 20097:00 amRNSAcquisition of 20:20 London

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.